Elekta AB (publ) - Asset Resilience Ratio
Elekta AB (publ) (EKTA-B) has an Asset Resilience Ratio of 9.18% as of January 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2025)
This chart shows how Elekta AB (publ)'s Asset Resilience Ratio has changed over time. Check EKTA-B strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Elekta AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Elekta AB (publ) (EKTA-B) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr2.54 Billion | 9.18% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr2.54 Billion | 9.18% |
Asset Resilience Insights
- Limited Liquidity: Elekta AB (publ) maintains only 9.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Elekta AB (publ) Industry Peers by Asset Resilience Ratio
Compare Elekta AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Elekta AB (publ) (2012–2025)
The table below shows the annual Asset Resilience Ratio data for Elekta AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-04-30 | 10.20% | Skr2.96 Billion ≈ $318.01 Million |
Skr28.98 Billion ≈ $3.12 Billion |
+3.24pp |
| 2024-04-30 | 6.96% | Skr2.19 Billion ≈ $235.14 Million |
Skr31.41 Billion ≈ $3.38 Billion |
-0.64pp |
| 2023-04-30 | 7.60% | Skr2.25 Billion ≈ $242.14 Million |
Skr29.61 Billion ≈ $3.19 Billion |
-4.10pp |
| 2022-04-30 | 11.70% | Skr3.08 Billion ≈ $331.13 Million |
Skr26.30 Billion ≈ $2.83 Billion |
-1.07pp |
| 2021-04-30 | 12.77% | Skr3.17 Billion ≈ $341.36 Million |
Skr24.84 Billion ≈ $2.67 Billion |
-5.63pp |
| 2020-04-30 | 18.40% | Skr5.23 Billion ≈ $562.62 Million |
Skr28.41 Billion ≈ $3.06 Billion |
+8.42pp |
| 2019-04-30 | 9.98% | Skr2.40 Billion ≈ $258.49 Million |
Skr24.06 Billion ≈ $2.59 Billion |
+1.81pp |
| 2018-04-30 | 8.17% | Skr1.83 Billion ≈ $197.37 Million |
Skr22.46 Billion ≈ $2.42 Billion |
+2.09pp |
| 2017-04-30 | 6.08% | Skr1.27 Billion ≈ $137.00 Million |
Skr20.95 Billion ≈ $2.25 Billion |
+7.87pp |
| 2016-04-30 | -1.80% | Skr-349.00 Million ≈ $-37.56 Million |
Skr19.44 Billion ≈ $2.09 Billion |
-0.12pp |
| 2015-04-30 | -1.67% | Skr-354.00 Million ≈ $-38.10 Million |
Skr21.18 Billion ≈ $2.28 Billion |
-45.02pp |
| 2012-04-30 | 43.35% | Skr6.60 Billion ≈ $710.70 Million |
Skr15.23 Billion ≈ $1.64 Billion |
-- |
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more